These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 24928723)

  • 1. Use of endogenous cortisol 6β-hydroxylation clearance for phenotyping in vivo CYP3A activity in women after sequential administration of an oral contraceptive (OC) containing ethinylestradiol and levonorgestrel as weak CYP3A inhibitors.
    Shibasaki H; Kuroiwa M; Uchikura S; Tsuboyama S; Yokokawa A; Kume M; Furuta T
    Steroids; 2014 Sep; 87():137-44. PubMed ID: 24928723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for the validity of cortisol 6 beta-hydroxylation clearance as a new index for in vivo cytochrome P450 3A phenotyping in humans.
    Furuta T; Suzuki A; Mori C; Shibasaki H; Yokokawa A; Kasuya Y
    Drug Metab Dispos; 2003 Nov; 31(11):1283-7. PubMed ID: 14570755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraindividual and interindividual variabilities in endogenous cortisol 6β-hydroxylation clearance as an index for in vivo CYP3A phenotyping in humans.
    Shibasaki H; Hosoda K; Goto M; Suzuki A; Yokokawa A; Ishii K; Furuta T
    Drug Metab Dispos; 2013 Feb; 41(2):475-9. PubMed ID: 23175666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma 6β-hydroxycortisol to cortisol ratio as a less invasive cytochrome P450 3A phenotyping method.
    Hirano R; Yokokawa A; Furihata T; Shibasaki H
    Br J Clin Pharmacol; 2024 Apr; 90(4):1016-1026. PubMed ID: 38102865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of cytochrome P450 2B6 activity by hormone replacement therapy and oral contraceptive as measured by bupropion hydroxylation.
    Palovaara S; Pelkonen O; Uusitalo J; Lundgren S; Laine K
    Clin Pharmacol Ther; 2003 Oct; 74(4):326-33. PubMed ID: 14534519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-dependent inhibition of CYP3A activity by clarithromycin during Helicobacter pylori eradication therapy assessed by changes in plasma lansoprazole levels and partial cortisol clearance to 6beta-hydroxycortisol.
    Ushiama H; Echizen H; Nachi S; Ohnishi A
    Clin Pharmacol Ther; 2002 Jul; 72(1):33-43. PubMed ID: 12152002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can oral contraceptive steroids influence the elimination of nifedipine and its primary pryidine metabolite in humans?
    Balogh A; Gessinger S; Svarovsky U; Hippius M; Mellinger U; Klinger G; Hoffmann A; Oettel M
    Eur J Clin Pharmacol; 1998; 54(9-10):729-34. PubMed ID: 9923576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamic and pharmacokinetic evaluation of coadministration of lacosamide and an oral contraceptive (levonorgestrel plus ethinylestradiol) in healthy female volunteers.
    Cawello W; Rosenkranz B; Schmid B; Wierich W
    Epilepsia; 2013 Mar; 54(3):530-6. PubMed ID: 23360419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
    Meijers JC; Middeldorp S; Tekelenburg W; van den Ende AE; Tans G; Prins MH; Rosing J; Büller HR; Bouma BN
    Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulatory and Inhibitory Effects of Steroid Hormones and Human Cytochrome P450 (CYP) 3A Inhibitors on Cortisol 6β-Hydroxylation Catalyzed by CYP3A Subfamilies.
    Niwa T; Tani M; Suzuki A; Murakami M
    Drug Metab Bioanal Lett; 2023; 16(2):73-80. PubMed ID: 37649294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of CYP3A activity in humans using three different parameters based on endogenous cortisol metabolism.
    Luo X; Li XM; Hu ZY; Cheng ZN
    Acta Pharmacol Sin; 2009 Sep; 30(9):1323-9. PubMed ID: 19701237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative prediction of hepatic CYP3A activity using endogenous markers in healthy subjects after administration of CYP3A inhibitors or inducers.
    Lee J; Yoon SH; Yi S; Kim AH; Kim B; Lee S; Yu KS; Jang IJ; Cho JY
    Drug Metab Pharmacokinet; 2019 Aug; 34(4):247-252. PubMed ID: 31088714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary 6β-Hydroxycortisol/Cortisol Ratio Most Highly Correlates With Midazolam Clearance Under Hepatic CYP3A Inhibition and Induction in Females: A Pharmacometabolomics Approach.
    Shin KH; Ahn LY; Choi MH; Moon JY; Lee J; Jang IJ; Yu KS; Cho JY
    AAPS J; 2016 Sep; 18(5):1254-1261. PubMed ID: 27317471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of an oral contraceptive preparation containing ethinylestradiol and gestodene on CYP3A4 activity as measured by midazolam 1'-hydroxylation.
    Palovaara S; Kivistö KT; Tapanainen P; Manninen P; Neuvonen PJ; Laine K
    Br J Clin Pharmacol; 2000 Oct; 50(4):333-7. PubMed ID: 11012556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of 6β-Hydroxycortisol and 6β-Hydroxycortisone as Biomarkers for Cytochrome P450 3A Activity: Insight into Their Predictive Value for Estimating Oral Immunosuppressant Metabolism.
    Luo X; Zheng L; Cai N; Liu Q; Yang S; He X; Cheng Z
    J Pharm Sci; 2015 Oct; 104(10):3578-86. PubMed ID: 26150050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships between Endogenous Plasma Biomarkers of Constitutive Cytochrome P450 3A Activity and Single-Time-Point Oral Midazolam Microdose Phenotype in Healthy Subjects.
    Woolsey SJ; Beaton MD; Choi YH; Dresser GK; Gryn SE; Kim RB; Tirona RG
    Basic Clin Pharmacol Toxicol; 2016 Apr; 118(4):284-91. PubMed ID: 26399557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of steroid hormone hydroxylation mediated by cytochrome P450 3A subfamilies.
    Niwa T; Okamoto A; Narita K; Toyota M; Kato K; Kobayashi K; Sasaki S
    Arch Biochem Biophys; 2020 Mar; 682():108283. PubMed ID: 32001245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous cortisol 6 beta-hydroxylation clearance is not an accurate probe for overall cytochrome P450 3A phenotyping in humans.
    Hu ZY; Zhao YS; Wu D; Cheng ZN
    Clin Chim Acta; 2009 Oct; 408(1-2):92-7. PubMed ID: 19654004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of brivaracetam (400 mg/day) on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive in healthy women.
    Stockis A; Rolan P
    J Clin Pharmacol; 2013 Dec; 53(12):1313-21. PubMed ID: 24386664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways.
    Tans G; Curvers J; Middeldorp S; Thomassen MC; Meijers JC; Prins MH; Bouma BN; Büller HR; Rosing J
    Thromb Haemost; 2000 Jul; 84(1):15-21. PubMed ID: 10928463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.